Quinazoline derivatives

US7205309B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Patrizio Mattei · Riehen, CH
• Werner Mueller · Cologne, DE
• Werner Neidhart · Hagenthal-le-Bas, FR
• Matthias Nettekoven · Weil am Rhein, DE
• Philippe Pflieger · Schwoben, FR

Key dates

• Filing date: Jul 3, 2003
• Grant date: Apr 17, 2007
• Expiry date: Mar 15, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D405/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula Ias well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3 and A have the significance given in the specification are provided. The compounds can be used for the treatment or prevention of obesity.